CINECA IRIS Institutional Research Information System

MASSAIA, Massimo Giovanni Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.609
EU - Europa 1.764
AS - Asia 791
SA - Sud America 55
AF - Africa 38
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5.295
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.545
DE - Germania 581
IT - Italia 483
CN - Cina 342
GB - Regno Unito 148
FR - Francia 138
IN - India 98
VN - Vietnam 76
KR - Corea 59
PL - Polonia 56
CA - Canada 54
RU - Federazione Russa 53
JP - Giappone 46
CZ - Repubblica Ceca 42
NL - Olanda 42
HK - Hong Kong 31
AU - Australia 30
ES - Italia 29
TW - Taiwan 28
CH - Svizzera 25
ZA - Sudafrica 24
BR - Brasile 21
SG - Singapore 21
TR - Turchia 21
IE - Irlanda 19
CL - Cile 18
BE - Belgio 17
DK - Danimarca 16
PT - Portogallo 16
FI - Finlandia 15
UA - Ucraina 14
IL - Israele 12
SE - Svezia 11
AT - Austria 10
GR - Grecia 10
MX - Messico 9
EG - Egitto 8
ID - Indonesia 8
RS - Serbia 8
SA - Arabia Saudita 8
CO - Colombia 7
HU - Ungheria 7
NO - Norvegia 6
IQ - Iraq 5
PH - Filippine 5
PK - Pakistan 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
AP - ???statistics.table.value.countryCode.AP??? 4
MK - Macedonia 4
MY - Malesia 4
NZ - Nuova Zelanda 4
AR - Argentina 3
DZ - Algeria 3
HR - Croazia 3
IR - Iran 3
NP - Nepal 3
PE - Perù 3
RO - Romania 3
BO - Bolivia 2
LT - Lituania 2
LU - Lussemburgo 2
QA - Qatar 2
BG - Bulgaria 1
BH - Bahrain 1
CY - Cipro 1
EC - Ecuador 1
EE - Estonia 1
HN - Honduras 1
KZ - Kazakistan 1
MA - Marocco 1
NG - Nigeria 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
Totale 5.295
Salva come PNG Salva come JPEG
Città #
Fairfield 256
Ashburn 196
Houston 194
Seattle 161
Buffalo 149
Woodbridge 146
Santa Cruz 131
Torino 126
Cambridge 113
Shanghai 88
Wilmington 86
Ann Arbor 84
Dong Ket 62
Chicago 53
Beijing 51
Nürnberg 48
Warsaw 47
University Park 46
Turin 41
Pisa 39
Los Angeles 33
San Diego 33
Las Vegas 30
Mountain View 29
Rome 24
Tokyo 23
Wuhan 23
Milan 20
Leawood 19
Muizenberg 19
Ottawa 19
Dublin 18
Taipei 18
Bengaluru 17
Hangzhou 16
Nanjing 16
New York 16
Boardman 14
Clearwater 14
Dallas 14
Henderson 14
Lake Forest 14
Duncan 13
Des Moines 12
College Park 11
Guangzhou 11
Helsinki 11
Phoenix 11
Amsterdam 10
Chengdu 10
San Jose 10
Southampton 10
Hyderabad 9
Santiago 9
Toronto 9
Jakarta 8
Moscow 8
Paris 8
Raritan 8
San Francisco 8
Shenyang 8
Singapore 8
Copenhagen 7
Madrid 7
Melbourne 7
Providence 7
Bogotá 6
Florence 6
Istanbul 6
Lisbon 6
London 6
Novara 6
Padova 6
Redmond 6
Rotterdam 6
Shatin 6
São Paulo 6
Bologna 5
Central District 5
Chaville 5
Chennai 5
Chongqing 5
Costa Mesa 5
Derby 5
Detroit 5
Fleming Island 5
Frederiksberg 5
Marseille 5
Mumbai 5
Newark 5
Piemonte 5
Provo 5
Seoul 5
Vienna 5
Athens 4
Austin 4
Baltimore 4
Berlin 4
Bordeaux 4
Boulder 4
Totale 2.955
Salva come PNG Salva come JPEG
Nome #
Chicago 2014 - 30 years of γδ T cells, file e27ce429-3c32-2581-e053-d805fe0acbaa 558
Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting), file e27ce428-a310-2581-e053-d805fe0acbaa 448
Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma., file e27ce426-fca2-2581-e053-d805fe0acbaa 395
Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients, file e27ce429-486b-2581-e053-d805fe0acbaa 394
Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile, file e27ce429-43a6-2581-e053-d805fe0acbaa 292
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia, file e27ce429-39e8-2581-e053-d805fe0acbaa 236
Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma, file e27ce427-79db-2581-e053-d805fe0acbaa 232
Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells, file e27ce427-83a5-2581-e053-d805fe0acbaa 206
The ATP-binding cassette transporter A1 regulates phosphoantigen release and Vγ9Vδ2 T cell activation by dendritic cells, file e27ce42b-bd7f-2581-e053-d805fe0acbaa 205
Amplification of T cell activation induced by CD73 (ecto-5' nucleotidase) engagement., file e27ce429-58b2-2581-e053-d805fe0acbaa 194
IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells, file e27ce426-c0e0-2581-e053-d805fe0acbaa 152
Management of multiple myeloma and related-disorders: guidelines from the Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES) and Italian Group for Bone Marrow Transplantation (GITMO), file e27ce429-3c23-2581-e053-d805fe0acbaa 152
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: Correlation with biologically-based risk stratification, file e27ce42c-a6fd-2581-e053-d805fe0acbaa 136
Vγ9Vδ2 T cells as strategic weapons to improve the potency of immune checkpoint blockade and immune interventions in human myeloma, file e27ce42d-5312-2581-e053-d805fe0acbaa 126
Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients, file e27ce434-8c3d-2581-e053-d805fe0acbaa 120
Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer, file e27ce42d-6f16-2581-e053-d805fe0acbaa 116
A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patients, file e27ce429-3c2a-2581-e053-d805fe0acbaa 115
ABCA1, apoA-I, and BTN3A1: A Legitimate ménage à trois in dendritic cells, file e27ce42d-0582-2581-e053-d805fe0acbaa 109
Vγ9Vδ2 T Cells in the Bone Marrow of Myeloma Patients: A Paradigm of Microenvironment-Induced Immune Suppression, file e27ce42c-fa2d-2581-e053-d805fe0acbaa 104
Clinicopathologic spectrum of cutaneous diseases in patients with hematologic malignancies with or without allogeneic bone marrow transplantation: an observational cohort study in 101 patients., file e27ce426-fa98-2581-e053-d805fe0acbaa 96
HIF-1α is overexpressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia, file e27ce42e-ef9d-2581-e053-d805fe0acbaa 92
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia, file e27ce42a-8c1f-2581-e053-d805fe0acbaa 85
Inhibition of the mevalonate pathway to override chemoresistance and promote immunogenic cell death in cancer cells: hitting two birds with one stone., file e27ce426-f939-2581-e053-d805fe0acbaa 80
The immune suppressive tumor microenvironment in multiple myeloma: The contribution of myeloid-derived suppressor cells, file 5963305a-5979-4ee3-b979-3656bbe15e79 78
MODULATION OF THE IMMUNE MICROENVIROMENT IN MULTIPLE MYELOMA PATIENTS TREATED WITH DARATUMUMABBASED THERAPY: TUMOR CELL-EXTRINSIC EFFECTS OF DARATUMUMAB TREATMENT, file 8778cfed-0853-43b7-8320-9068f294ea66 78
A Score-Based Approach to18F-FDG PET Images as a Tool to Describe Metabolic Predictors of Myocardial Doxorubicin Susceptibility, file e27ce42c-a6fa-2581-e053-d805fe0acbaa 76
HIF-1α is overexpressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia, file e27ce430-5244-2581-e053-d805fe0acbaa 65
CD157 signaling promotes survival of acute myeloid leukemia cells and modulates sensitivity to cytarabine through regulation of anti-apoptotic Mcl-1., file e27ce433-4c6b-2581-e053-d805fe0acbaa 63
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study, file e27ce434-fa8a-2581-e053-d805fe0acbaa 56
Microvesicles released from multiple myeloma cells are equipped with ectoenzymes belonging to canonical and non-canonical adenosinergic pathways and produce adenosine from ATP and NAD., file e27ce42e-a568-2581-e053-d805fe0acbaa 55
IMMUNE SUPPRESSION OF BONE MARROW Vγ9Vδ2 T CELLS BY BONE MARROW STROMAL CELLS (BMSC) IN MULTIPLE MYELOMA, file 759d509a-84bc-463f-bf96-c514112797c4 40
Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer Cells, file e27ce426-e647-2581-e053-d805fe0acbaa 40
Regulation of HIF-1α in TP53 Disrupted Chronic Lymphocytic Leukemia Cells and Its Potential Role as a Therapeutic Target, file e27ce42e-24b0-2581-e053-d805fe0acbaa 39
Immunoglobulin M (IgM) multiple myeloma versus Waldenström macroglobulinemia: Diagnostic challenges and therapeutic options: Two case reports, file e27ce435-00fa-2581-e053-d805fe0acbaa 33
Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients, file e6ae021b-25ef-48d5-91bc-e38acd892e13 27
Diagnosis of maternal Hodgkin lymphoma following abnormal findings at noninvasive prenatal screening test (NIPT): Report of two cases, file e27ce434-b4cb-2581-e053-d805fe0acbaa 23
CD157 reduces acutemyeloid leukemia cell sensitivity tocytarabine through upregulation of MCL-1 anti-apoptotic protein, file e27ce42e-97b3-2581-e053-d805fe0acbaa 20
Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma, file e27ce427-b3d4-2581-e053-d805fe0acbaa 18
Atypical chronic myeloid leukemia: New developments from molecular diagnosis to treatment, file e27ce434-b99a-2581-e053-d805fe0acbaa 18
Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time?, file 3a2ca262-e7df-43cf-91bd-e63b331a038f 14
CD157 signaling promotes survival of acute myeloid leukemia cells and modulates sensitivity to cytarabine through regulation of anti-apoptotic Mcl-1., file e27ce433-4c6c-2581-e053-d805fe0acbaa 12
MULTIFACETED IMMUNE CHECKPOINT EXPRESSION AND SENESCENT MARKERS IMPAIRS BONE MARROW Vγ9Vδ2 T-CELL FUNCTION IN MULTIPLE MYELOMA PATIENTS, file 70c27414-694d-445a-b99d-4276d79f0c3e 11
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies, file e27ce432-cc42-2581-e053-d805fe0acbaa 11
Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma, file e27ce426-aeab-2581-e053-d805fe0acbaa 10
CD157 REGULATES THE SENSITIVITY OF ACUTE MYELOID LEUKEMIA CELLS TO CHEMOTHERAPY BY MODULATING THE APOPTOTIC RESPONSE, file e27ce42e-97b5-2581-e053-d805fe0acbaa 8
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: Evidences from long term follow-up, file e27ce42c-a111-2581-e053-d805fe0acbaa 7
Immune dysfunctions affecting bone marrow Vγ9Vδ2 T cells in multiple myeloma: Role of immune checkpoints and disease status, file 198819b3-8c00-465b-8a3e-8935cefc4fb0 6
IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells, file e27ce426-c0e1-2581-e053-d805fe0acbaa 6
Idiotype vaccination in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapy., file e27ce42a-c7d6-2581-e053-d805fe0acbaa 6
Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasms, file e27ce42e-2c4c-2581-e053-d805fe0acbaa 6
SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia, file 610b6390-47da-486e-9c63-d2950cac72d8 5
High rate of durable responses with undetectable minimal residual disease with frontline venetoclax and rituximab in young and fit patients with chronic lymphocytic leukemia and an adverse biologic profile: results of the gimema phase II LLC1518 - 'Veritas' study, file 64042bde-855f-4f15-893a-87806cc7eecc 5
Severe and long-lasting disruption of T-cell receptor diversity in human myeloma after high-dose chemotherapy and autologous peripheral blood progenitor cell infusion., file e27ce42a-b7d4-2581-e053-d805fe0acbaa 5
Anticancer innovative therapy: Highlights from the ninth annual meeting, file e27ce434-bc76-2581-e053-d805fe0acbaa 5
Lack of efficacy of convalescent plasma in COVID-19 patients with concomitant hematological malignancies: An Italian retrospective study, file e7fe1f2e-1278-4f69-83cb-6ddec4ced9f7 5
Exposure to myeloma cell lysates affects the immune competence of dendritic cells and favors the induction of Tr1-like regulatory T cells, file e27ce426-b455-2581-e053-d805fe0acbaa 4
A Position Paper on IgM-Enriched Intravenous Immunoglobulin Adjunctive Therapy in Severe Acute Bacterial Infections: The TO-PIRO SCORE Proposal, file e27ce432-212c-2581-e053-d805fe0acbaa 4
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV, file 518cc494-3e93-4ee2-9629-25e7fbce3a70 3
Surgery and Prophylaxis with Susoctocog-Alfa in Acquired Hemophilia: Case Series and Literature Review, file 63822080-5ea9-4e89-aa25-27b363181f40 3
Immune Modulation by Zoledronic Acid in Human Myeloma: An Advantageous Cross Talk between V{gamma}9V{delta}2 T Cells, {alpha}{beta} CD8+ T Cells, Regulatory T Cells, and Dendritic Cells, file e27ce426-d90d-2581-e053-d805fe0acbaa 3
Molecular dynamics of targeting CD38 in multiple myeloma, file e27ce434-cee5-2581-e053-d805fe0acbaa 3
IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells, file e27ce426-c0df-2581-e053-d805fe0acbaa 2
Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells., file e27ce426-ef1f-2581-e053-d805fe0acbaa 2
Metabolic approaches to rescue antitumor Vγ9Vδ2 T-cell functions in myeloma, file e27ce42e-f6a2-2581-e053-d805fe0acbaa 2
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study, file e27ce431-0c1e-2581-e053-d805fe0acbaa 2
Microvesicles released from multiple myeloma cells are equipped with ectoenzymes belonging to canonical and non-canonical adenosinergic pathways and produce adenosine from ATP and NAD., file e27ce432-4436-2581-e053-d805fe0acbaa 2
Preclinical efficacy of carfilzomib in BRAF-mutant colorectal cancer models, file 7408d2ea-9bcd-4763-a5c8-f33d578565e7 1
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort, file a7b5b7e0-fb1e-4c50-940d-763d1eed0f4b 1
A comparison of allografting with autografting for newly diagnosed myeloma, file e27ce426-ab5e-2581-e053-d805fe0acbaa 1
New drugs for treatment of multiple myeloma, file e27ce426-aeb0-2581-e053-d805fe0acbaa 1
Telomere length is an independent predictor of survival, treatment requirement and Richter’s syndrome transformation in chronic lymphocytic leukemia, file e27ce426-b2e6-2581-e053-d805fe0acbaa 1
Zoledronic acid repolarizes tumor-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway, file e27ce426-b3b3-2581-e053-d805fe0acbaa 1
Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target molecule., file e27ce426-e339-2581-e053-d805fe0acbaa 1
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia, file e27ce42a-be6b-2581-e053-d805fe0acbaa 1
Totale 5.532
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.817
article - articoli 0
book - libri 0
conference - conferenze 287
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.104
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019338 0 0 0 0 0 0 0 0 0 71 167 100
2019/2020854 75 59 46 101 68 66 74 70 100 53 59 83
2020/2021954 54 106 70 54 84 79 56 74 75 119 65 118
2021/20221.168 107 79 50 127 95 48 100 95 88 71 176 132
2022/2023844 30 52 164 113 42 51 55 79 113 76 55 14
2023/2024403 29 19 31 43 51 39 59 59 36 37 0 0
Totale 5.532